Institutional investors hold a majority ownership of MYL through the 90.80% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2014, these large investors purchased a net $1.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 10.1 Million shares of Mylan Inc
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 5.3 Million shares of Mylan Inc
LAZARD ASSET MANAGEMENT LLC Bought 4.3 Million shares of Mylan Inc